InspireMD, Inc. Chief Financial Officer Michael A. Lawless filed a Form 4 on November 17, 2026, disclosing the purchase of 115,385 shares of common stock and acquisition of 86,539 Series L common stock warrants on November 13, 2026, through the company's underwritten public offering.

Key Highlights

  • Purchase date: Michael A. Lawless acquired 115,385 shares of common stock on November 13, 2026.
  • Price paid: The shares were purchased at a combined public offering price of $0.65 per share of common stock and accompanying Series L common stock warrants.
  • Warrants acquired: Lawless also acquired 86,539 Series L common stock warrants at $0.00 price, exercisable at $0.65 per share and expiring November 16, 2027.
  • Resulting ownership: Following the transaction, Lawless directly beneficially owned 807,080 shares of common stock.
  • Offering context: The shares were purchased in InspireMD's underwritten public offering, according to the filing.

InspireMD CFO Participates in Underwritten Public Offering at $0.65

According to the Form 4 filed with the SEC on November 17, 2026, Michael A. Lawless, Chief Financial Officer of InspireMD, Inc. (NASDAQ:NSPR), reported the acquisition of 115,385 shares of common stock on November 13, 2026. The filing indicates the transaction code was "P" (purchase), carried out at a price of $0.65 per share. The filing states this represents shares purchased "in the Issuer's underwritten public offering at a combined public offering price of $0.65 per share of common stock and accompanying Series L common stock warrants."

In addition to the common stock, the filing discloses that Lawless acquired 86,539 Series L common stock warrants on November 13, 2026, also coded as a purchase. According to the filing, the warrants are "immediately exercisable at an exercise price of $0.65 per share" and expire on November 16, 2027. The price of the derivative security is listed as $0.00, and Lawless directly beneficially owns 86,539 of these warrants following the transaction.

Following the reported common stock purchase, Lawless's direct beneficial ownership of InspireMD common stock stands at 807,080 shares, as reported in the filing. The Form 4 was filed by one reporting person and is not noted as an amendment to a prior filing.

What Was Disclosed

The filing reports that InspireMD CFO Michael A. Lawless purchased 115,385 shares of common stock and 86,539 Series L warrants on November 13, 2026, through InspireMD's underwritten public offering at $0.65 per unit, bringing his direct share ownership to 807,080.